Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis
Abstract
Tuberculosis (TB) is an infectious disease that affects millions of people globally, with 1.6 million deaths annually. TB treatment requires combinations of multiple different antibiotics for many months, and toxic side effects can occur.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 17, 2023
- Source ID
- 10.1128/spectrum.00465-23
Entities
People
- Antje Blumenthal
- David P. Fairlie
- Doris Hillemann
- Giorgia Mori
- Rachel F. Rollo
- Stefan Niemann
- Susanne Homolka
- Timothy Hill
Organizations
- Australian Research Council
- German Center for Infection Research
- National Health and Medical Research Council
- Research Center Borstel
- United States Department of Defense
- University of Queensland